• Je něco špatně v tomto záznamu ?

Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation

G. Dall'Ara, H. Eltchaninoff, N. Moat, C. Laroche, J. Goicolea, GP. Ussia, P. Kala, P. Wenaweser, M. Zembala, G. Nickenig, T. Snow, S. Price, EA. Barrero, R. Estevez-Loureiro, B. Iung, JL. Zamorano, G. Schuler, O. Alfieri, B. Prendergast, P....

. 2014 ; 177 (2) : 448-54. [pub] 20140928

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031675

BACKGROUND: There is great variability for the type of anaesthesia used during TAVI, with no clear consensus coming from comparative studies or guidelines. We sought to detect regional differences in the anaesthetic management of patients undergoing transcatheter aortic valve implantation (TAVI) in Europe and to evaluate the relationship between type of anaesthesia and in-hospital and 1 year outcome. METHODS: Between January 2011 and May 2012 the Sentinel European TAVI Pilot Registry enrolled 2807 patients treated via a transfemoral approach using either local (LA-group, 1095 patients, 39%) or general anaesthesia (GA-group, 1712 patients, 61%). RESULTS: A wide variation in LA use was evident amongst the 10 participating countries. The use of LA has increased over time (from a mean of 37.5% of procedures in the first year, to 57% in last 6 months, p<0.01). MI, major stroke as well as in-hospital death rate (7.0% LA vs 5.3% GA, p=0.053) had a similar incidence between groups, confirmed in multivariate regression analysis after adjusting for confounders. Dividing our population in tertiles according to the Log-EuroSCORE we found similar mortality under LA, whilst mortality was higher in the highest risk tertile under GA. Survival at 1 year, compared by Kaplan-Meier analysis, was similar between groups (log-rank: p=0.1505). CONCLUSIONS: Selection of anaesthesia appears to be more influenced by national practice and operator preference than patient characteristics. In the absence of an observed difference in outcomes for either approach, there is no compelling argument to suggest that operators and centres should change their anaesthetic practice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031675
003      
CZ-PrNML
005      
20181126145955.0
007      
ta
008      
151005s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijcard.2014.09.025 $2 doi
035    __
$a (PubMed)25443245
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Dall'Ara, Gianni $u NIHR Cardiovascular BRU, Royal Brompton Hospital, London, United Kingdom.
245    10
$a Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation / $c G. Dall'Ara, H. Eltchaninoff, N. Moat, C. Laroche, J. Goicolea, GP. Ussia, P. Kala, P. Wenaweser, M. Zembala, G. Nickenig, T. Snow, S. Price, EA. Barrero, R. Estevez-Loureiro, B. Iung, JL. Zamorano, G. Schuler, O. Alfieri, B. Prendergast, P. Ludman, S. Windecker, M. Sabate, M. Gilard, A. Witkowski, H. Danenberg, E. Schroeder, F. Romeo, C. Macaya, G. Derumeaux, A. Mattesini, L. Tavazzi, C. Di Mario, . ,
520    9_
$a BACKGROUND: There is great variability for the type of anaesthesia used during TAVI, with no clear consensus coming from comparative studies or guidelines. We sought to detect regional differences in the anaesthetic management of patients undergoing transcatheter aortic valve implantation (TAVI) in Europe and to evaluate the relationship between type of anaesthesia and in-hospital and 1 year outcome. METHODS: Between January 2011 and May 2012 the Sentinel European TAVI Pilot Registry enrolled 2807 patients treated via a transfemoral approach using either local (LA-group, 1095 patients, 39%) or general anaesthesia (GA-group, 1712 patients, 61%). RESULTS: A wide variation in LA use was evident amongst the 10 participating countries. The use of LA has increased over time (from a mean of 37.5% of procedures in the first year, to 57% in last 6 months, p<0.01). MI, major stroke as well as in-hospital death rate (7.0% LA vs 5.3% GA, p=0.053) had a similar incidence between groups, confirmed in multivariate regression analysis after adjusting for confounders. Dividing our population in tertiles according to the Log-EuroSCORE we found similar mortality under LA, whilst mortality was higher in the highest risk tertile under GA. Survival at 1 year, compared by Kaplan-Meier analysis, was similar between groups (log-rank: p=0.1505). CONCLUSIONS: Selection of anaesthesia appears to be more influenced by national practice and operator preference than patient characteristics. In the absence of an observed difference in outcomes for either approach, there is no compelling argument to suggest that operators and centres should change their anaesthetic practice.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a celková anestezie $x metody $x mortalita $7 D000768
650    _2
$a lokální anestezie $x metody $x mortalita $7 D000772
650    _2
$a aortální stenóza $x mortalita $x chirurgie $7 D001024
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pilotní projekty $7 D010865
650    _2
$a registrace $7 D012042
650    _2
$a transkatetrální implantace aortální chlopně $x metody $x mortalita $7 D065467
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Eltchaninoff, Helene $u University Hospital, Rouen, France.
700    1_
$a Moat, Neil $u NIHR Cardiovascular BRU, Royal Brompton Hospital, London, United Kingdom.
700    1_
$a Laroche, Cécile $u EurObservational Reasearch Progamme Department, European Society of Cardiology, Sophia-Antipolis, France.
700    1_
$a Goicolea, Javier $u Hospital Universita Puerta de Hierro, Madrid, Spain.
700    1_
$a Ussia, Gian Paolo $u University of Rome Tor Vergata, Rome, Italy.
700    1_
$a Kala, Petr $u Masaryk University, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Wenaweser, Peter $u Bern University Hospital, Bern, Switzerland.
700    1_
$a Zembala, Marian $u Silesian Centre for Heart Disease, Zabrze, Poland.
700    1_
$a Nickenig, Georg $u University Hospital, Bonn, Germany.
700    1_
$a Snow, Thomas $u St. Thomas' Hospital, London, United Kingdom.
700    1_
$a Price, Susanna $u NIHR Cardiovascular BRU, Royal Brompton Hospital, London, United Kingdom.
700    1_
$a Barrero, Eduardo Alegria $u Hospital Universitario de Torrejon, Madrid, Spain.
700    1_
$a Estevez-Loureiro, Rodrigo $u Complejo Asistencial Universitario de Leon, Leon, Spain.
700    1_
$a Iung, Bernard $u Bichat Hospital, Paris, France.
700    1_
$a Zamorano, José Luis $u Hospital Universitario Ramon y Cajall, Madrid, Spain.
700    1_
$a Schuler, Gerhard $u Herzzentrum Leipzig Abt. Kardiologie und Angiologie, Leipzig, Germany.
700    1_
$a Alfieri, Ottavio $u Ospedale San Raffaele, Milan, Italy. $7 gn_A_00004089
700    1_
$a Prendergast, Bernard $u John Radcliffe Hospital, Oxford, United Kingdom.
700    1_
$a Ludman, Peter $u Queen Elizabeth Hospital, Birmingham, United Kingdom.
700    1_
$a Windecker, Stephan $7 xx0229768 $u Bern University Hospital, Bern, Switzerland.
700    1_
$a Sabate, Manel $u Thorax Institute, Hospital Clinic, Barcelona, Spain.
700    1_
$a Gilard, Martine $u Centre Hospitalier Universitaire (CHU) Brest, Brest, France.
700    1_
$a Witkowski, Adam $u Institute of Cardiology, Warsaw, Poland.
700    1_
$a Danenberg, Haim $u Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
700    1_
$a Schroeder, Erwin $u UCL de Mont-Godinne, Yvoir, Belgium.
700    1_
$a Romeo, Francesco $u University of Rome Tor Vergata, Rome, Italy.
700    1_
$a Macaya, Carlos $u Clinico 'San Carlos' University Hospital, Madrid, Spain.
700    1_
$a Derumeaux, Genevieve $u University of Lyon, Lyon, France.
700    1_
$a Mattesini, Alessio $u NIHR Cardiovascular BRU, Royal Brompton Hospital, London, United Kingdom.
700    1_
$a Tavazzi, Luigi $u Maria Cecilia Hospital GVM Care & Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
700    1_
$a Di Mario, Carlo $u NIHR Cardiovascular BRU, Royal Brompton Hospital, London, United Kingdom. Electronic address: c.dimario@rbht.nhs.uk.
700    1_
$a ,
773    0_
$w MED00002299 $t International journal of cardiology $x 1874-1754 $g Roč. 177, č. 2 (2014), s. 448-54
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25443245 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20181126150058 $b ABA008
999    __
$a ok $b bmc $g 1092551 $s 914801
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 177 $c 2 $d 448-54 $e 20140928 $i 1874-1754 $m International journal of cardiology $n Int J Cardiol $x MED00002299
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace